Literature DB >> 32857842

The Veterans Aging Cohort Study (VACS) Index Predicts Mortality in a Community-recruited Cohort of People With Human Immunodeficiency Virus (HIV) Who Use Illicit Drugs.

Hudson Reddon1,2, Cameron Grant1, Ekaterina Nosova1, Nadia Fairbairn1,3, Rolando Barrios4, Amy C Justice5,6, Seonaid Nolan1,3, M Eugenia Socias1,3, M-J Milloy1,3.   

Abstract

The Veterans Aging Cohort Study (VACS) index combines commonly collected clinical biomarkers to estimate human immunodeficiency virus (HIV) disease severity. Among a prospective cohort of people living with HIV who use illicit drugs (PWUD) (n = 948), we found that the VACS index was significantly associated with mortality over a 20-year study period.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; Restricted Index; VACS index; mortality; people who use drugs

Mesh：

Substances：

Year:  2021        PMID： 32857842      PMCID： PMC8496478          DOI： 10.1093/cid/ciaa1263

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  9 in total

1.  Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.

Authors:  Robert C Kalayjian; Rhoderick N Machekano; Nesrine Rizk; Gregory K Robbins; Rajesh T Gandhi; Benigno A Rodriguez; Richard B Pollard; Michael M Lederman; Alan Landay
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals.

Authors:  Kathleen M Akgün; Janet P Tate; Kristina Crothers; Stephen Crystal; David A Leaf; Julie Womack; Todd T Brown; Amy C Justice; Krisann K Oursler
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

3.  Barriers to use of free antiretroviral therapy in injection drug users.

Authors:  S A Strathdee; A Palepu; P G Cornelisse; B Yip; M V O'Shaughnessy; J S Montaner; M T Schechter; R S Hogg
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

4.  Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis.

Authors:  Amy C Justice; Sharada P Modur; Janet P Tate; Keri N Althoff; Lisa P Jacobson; Kelly A Gebo; Mari M Kitahata; Michael A Horberg; John T Brooks; Kate Buchacz; Sean B Rourke; Anita Rachlis; Sonia Napravnik; Joseph Eron; James H Willig; Richard Moore; Gregory D Kirk; Ronald Bosch; Benigno Rodriguez; Robert S Hogg; Jennifer Thorne; James J Goedert; Marina Klein; John Gill; Steven Deeks; Timothy R Sterling; Kathryn Anastos; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2013-02-01       Impact factor: 3.731

5.  Brief Report: Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users With Treated HIV Infection.

Authors:  Denise C Vidot; Jennifer A Manuzak; Nichole R Klatt; Suresh Pallikkuth; Margie Roach; Samantha E Dilworth; Savita Pahwa; Adam W Carrico
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.771

6.  An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

Authors:  Janet P Tate; Amy C Justice; Michael D Hughes; Fabrice Bonnet; Peter Reiss; Amanda Mocroft; Jacob Nattermann; Fiona C Lampe; Heiner C Bucher; Timothy R Sterling; Heidi M Crane; Mari M Kitahata; Margaret May; Jonathan A C Sterne
Journal:  AIDS       Date:  2013-02-20       Impact factor: 4.177

7.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069

8.  The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study.

Authors:  Sheldon T Brown; Janet P Tate; Tassos C Kyriakides; Katherine A Kirkwood; Mark Holodniy; Joseph L Goulet; Brian J Angus; D William Cameron; Amy C Justice
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

9.  Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Authors:  Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240
  9 in total
  2 in total

1.  Geriatric conditions and healthcare utilisation in older adults living with HIV.

Authors:  Meredith Greene; Ying Shi; John Boscardin; Rebecca Sudore; Monica Gandhi; Kenneth Covinsky
Journal:  Age Ageing       Date:  2022-05-01       Impact factor: 12.782

2.  Periods of Homelessness Linked to Higher VACS Index Among HIV-Positive People Who Use Drugs.

Authors:  Hudson Reddon; M Eugenia Socias; Amy Justice; Zishan Cui; Ekaterina Nosova; Rolando Barrios; Nadia Fairbairn; Brandon D L Marshall; M-J Milloy
Journal:  AIDS Behav       Date:  2022-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.